SK Life Science
NJ - ParamusBiotechnology
Focus: SK Life Science is a specialty pharma company focused on small-molecule CNS therapies, headquartered in Paramus, NJ. The company is publicly traded and heavily dependent on its lead epilepsy product XCOPRI (cenobamate).
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
13-2 this month
Stable — net -2 jobs in 30d
6 added, 8 removed. Backfill posture.
Should You Work at SK Life Science?
AI assessmentSK Life Science offers stability through a profitable, protected peak-stage asset but limited growth optionality and high restructuring risk if XCOPRI faces headwinds.
Why Work Here
- Peak-stage commercial asset: XCOPRI generated $113M in Part D spending and has patent protection until 2039, providing revenue stability and career continuity.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
14 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$113M Part DStable
Peak
Help build intelligence for SK Life Science
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.